Industry Research Reports

Home > Reports > Chemical & Material > Global Beta-Nicotinamide Mononucleotide (NMN) Market Research Report 2026

Global Beta-Nicotinamide Mononucleotide (NMN) Market Research Report 2026

Industry: Chemical & Material

Published Date: 2026-01-05

Pages: 132 Pages

Report ld: 5518333

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Beta-Nicotinamide Mononucleotide (NMN) Market Size(US$)

CAGR 2026-2032

13.4%

Market Size,2032

USD 1,112

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 524 million

Market Forecast in 2032(Value)

US$ 1,112 million

CAGR

13.4%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Beta-Nicotinamide Mononucleotide (NMN) market was valued at US$ 468 million in 2025 and is anticipated to reach US$ 1112 million by 2032, at a CAGR of 13.4% from 2026 to 2032.

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Beta-Nicotinamide Mononucleotide (NMN) competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.

NMN is a precursor of nicotinamide adenine dinucleotide (NAD+), which plays a vital role in cell metabolism and energy production. As we age, the level of NAD+ in the human body gradually decreases, resulting in weakened cell metabolism, which in turn triggers a series of aging-related diseases. Therefore, increasing the level of NAD+ in the body by supplementing NMN has become a new way to fight aging and maintain good health.

With the general improvement of global health awareness and continuous breakthroughs in scientific research and technology, the growth momentum of the NMN market will continue to increase. In the future, the NMN market will achieve a deeper cross-border integration with other health industries such as biotechnology, precision medicine, and nutritional supplements, giving rise to a series of innovative products and service models to meet consumers' more personalized and precise health needs.

At present, nicotinamide mononucleotide (NMN) is still in the development stage. There are not many manufacturers in the global market, and consumers have weak awareness of its use, especially in developing countries. The demand is lower than that in developed countries around the world, but the demand in developing countries is growing rapidly. Leading giants have proposed expansion plans and increased production bases.

Nicotinamide mononucleotide (NMN) core manufacturers include GeneHarbor, Mirailab Bioscience, Maac10 Formulas, Herbalmax and Genex Formula. China is the largest production area, accounting for about 84% of the global market share, followed by North America and Japan. The downstream applications of nicotinamide mononucleotide include health products, cosmetics, etc. Globally, health products are the largest application market, and raw materials for health products account for 99% of the total sales of nicotinamide mononucleotide in 2023.

This report delivers a comprehensive overview of the global Beta-Nicotinamide Mononucleotide (NMN) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Beta-Nicotinamide Mononucleotide (NMN). The Beta-Nicotinamide Mononucleotide (NMN) market size, estimates, and forecasts are provided in terms of shipments (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Beta-Nicotinamide Mononucleotide (NMN) market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Beta-Nicotinamide Mononucleotide (NMN) manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

MARKET SEGMENTATION

By Company

GeneHarbor
Herbalmax
Genex Formulas
Mirailab Bioscience
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway
ABA Chemical

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Content ≥98%
Content ＜98%

Segment by Application

Health Care Products
Cosmetics
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.

Chapter 2: Provides a detailed analysis of the competitive landscape for Beta-Nicotinamide Mononucleotide (NMN) manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.

Chapter 3: Examines Beta-Nicotinamide Mononucleotide (NMN) production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.

Chapter 4: Analyzes Beta-Nicotinamide Mononucleotide (NMN) consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.

Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.

Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.

Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.

Chapter 8: Reviews the industry value chain, including upstream and downstream segments.

Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.

Chapter 10: Summarizes the key findings and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Beta-Nicotinamide Mononucleotide (NMN) Market Overview

1.1 Product Definition

1.2 Beta-Nicotinamide Mononucleotide (NMN) by Type

1.2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Market Value Growth Rate Analysis by Type: 2025 vs 2032

1.2.2 Content ≥98%

1.2.3 Content ＜98%

1.3 Beta-Nicotinamide Mononucleotide (NMN) by Application

1.3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Market Value Growth Rate Analysis by Application: 2025 vs 2032

1.3.2 Health Care Products

1.3.3 Cosmetics

1.3.4 Others

1.4 Global Market Growth Prospects

1.4.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2021–2032)

1.4.2 Global Beta-Nicotinamide Mononucleotide (NMN) Production Capacity Estimates and Forecasts (2021–2032)

1.4.3 Global Beta-Nicotinamide Mononucleotide (NMN) Production Estimates and Forecasts (2021–2032)

1.4.4 Global Beta-Nicotinamide Mononucleotide (NMN) Market Average Price Estimates and Forecasts (2021–2032)

1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production Market Share by Manufacturers (2021–2026)

2.2 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Manufacturers (2021–2026)

2.3 Global Key Players of Beta-Nicotinamide Mononucleotide (NMN), Industry Ranking, 2024 vs 2025

2.4 Global Beta-Nicotinamide Mononucleotide (NMN) Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.5 Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Manufacturers (2021–2026)

2.6 Global Key Manufacturers of Beta-Nicotinamide Mononucleotide (NMN), Manufacturing Footprints and Headquarters

2.7 Global Key Manufacturers of Beta-Nicotinamide Mononucleotide (NMN), Product Offerings and Applications

2.8 Global Key Manufacturers of Beta-Nicotinamide Mononucleotide (NMN), Date of Entry into the Industry

2.9 Beta-Nicotinamide Mononucleotide (NMN) Market Competitive Situation and Trends

2.9.1 Beta-Nicotinamide Mononucleotide (NMN) Market Concentration Rate

2.9.2 Top 5 and Top 10 Global Beta-Nicotinamide Mononucleotide (NMN) Players Market Share by Revenue

2.10 Mergers & Acquisitions and Expansion

3 Beta-Nicotinamide Mononucleotide (NMN) Production by Region

3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032

3.2 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value by Region (2021–2032)

3.2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value by Region (2021–2026)

3.2.2 Global Forecasted Production Value of Beta-Nicotinamide Mononucleotide (NMN) by Region (2027–2032)

3.3 Global Beta-Nicotinamide Mononucleotide (NMN) Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032

3.4 Global Beta-Nicotinamide Mononucleotide (NMN) Production Volume by Region (2021–2032)

3.4.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production by Region (2021–2026)

3.4.2 Global Forecasted Production of Beta-Nicotinamide Mononucleotide (NMN) by Region (2027–2032)

3.5 Global Beta-Nicotinamide Mononucleotide (NMN) Market Price Analysis by Region (2021–2026)

3.6 Global Beta-Nicotinamide Mononucleotide (NMN) Production, Value, and Year-over-Year Growth

3.6.1 North America Beta-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2021–2032)

3.6.2 China Beta-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2021–2032)

3.6.3 Japan Beta-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2021–2032)

4 Beta-Nicotinamide Mononucleotide (NMN) Consumption by Region

4.1 Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032

4.2 Global Beta-Nicotinamide Mononucleotide (NMN) Consumption by Region (2021–2032)

4.2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Consumption by Region (2021–2026)

4.2.2 Global Beta-Nicotinamide Mononucleotide (NMN) Forecasted Consumption by Region (2027–2032)

4.3 North America

4.3.1 North America Beta-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032

4.3.2 North America Beta-Nicotinamide Mononucleotide (NMN) Consumption by Country (2021–2032)

4.3.3 U.S.

4.3.4 Canada

4.4 Europe

4.4.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032

4.4.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Consumption by Country (2021–2032)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Russia

4.5 Asia Pacific

4.5.1 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Region: 2021 vs 2025 vs 2032

4.5.2 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Consumption by Region (2021–2032)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032

4.6.2 Latin America, Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Consumption by Country (2021–2032)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

4.6.6 GCC Countries

5 Segment by Type

5.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production by Type (2021–2032)

5.1.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production by Type (2021–2026)

5.1.2 Global Beta-Nicotinamide Mononucleotide (NMN) Production by Type (2027–2032)

5.1.3 Global Beta-Nicotinamide Mononucleotide (NMN) Production Market Share by Type (2021–2032)

5.2 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value by Type (2021–2032)

5.2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value by Type (2021–2026)

5.2.2 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value by Type (2027–2032)

5.2.3 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Type (2021–2032)

5.3 Global Beta-Nicotinamide Mononucleotide (NMN) Price by Type (2021–2032)

6 Segment by Application

6.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production by Application (2021–2032)

6.1.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production by Application (2021–2026)

6.1.2 Global Beta-Nicotinamide Mononucleotide (NMN) Production by Application (2027–2032)

6.1.3 Global Beta-Nicotinamide Mononucleotide (NMN) Production Market Share by Application (2021–2032)

6.2 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value by Application (2021–2032)

6.2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value by Application (2021–2026)

6.2.2 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value by Application (2027–2032)

6.2.3 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Application (2021–2032)

6.3 Global Beta-Nicotinamide Mononucleotide (NMN) Price by Application (2021–2032)

7 Key Companies Profiled

7.1 GeneHarbor

7.1.1 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Company Information

7.1.2 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Product Portfolio

7.1.3 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Production, Value, Price, and Gross Margin (2021–2026)

7.1.4 GeneHarbor Main Business and Markets Served

7.1.5 GeneHarbor Recent Developments/Updates

7.2 Herbalmax

7.2.1 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Company Information

7.2.2 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Product Portfolio

7.2.3 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Production, Value, Price, and Gross Margin (2021–2026)

7.2.4 Herbalmax Main Business and Markets Served

7.2.5 Herbalmax Recent Developments/Updates

7.3 Genex Formulas

7.3.1 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Company Information

7.3.2 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Product Portfolio

7.3.3 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Production, Value, Price, and Gross Margin (2021–2026)

7.3.4 Genex Formulas Main Business and Markets Served

7.3.5 Genex Formulas Recent Developments/Updates

7.4 Mirailab Bioscience

7.4.1 Mirailab Bioscience Beta-Nicotinamide Mononucleotide (NMN) Company Information

7.4.2 Mirailab Bioscience Beta-Nicotinamide Mononucleotide (NMN) Product Portfolio

7.4.3 Mirailab Bioscience Beta-Nicotinamide Mononucleotide (NMN) Production, Value, Price, and Gross Margin (2021–2026)

7.4.4 Mirailab Bioscience Main Business and Markets Served

7.4.5 Mirailab Bioscience Recent Developments/Updates

7.5 Maac10 Formulas

7.5.1 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Company Information

7.5.2 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Product Portfolio

7.5.3 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Production, Value, Price, and Gross Margin (2021–2026)

7.5.4 Maac10 Formulas Main Business and Markets Served

7.5.5 Maac10 Formulas Recent Developments/Updates

7.6 EffePharm

7.6.1 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Company Information

7.6.2 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Product Portfolio

7.6.3 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Production, Value, Price, and Gross Margin (2021–2026)

7.6.4 EffePharm Main Business and Markets Served

7.6.5 EffePharm Recent Developments/Updates

7.7 Bontac

7.7.1 Bontac Beta-Nicotinamide Mononucleotide (NMN) Company Information

7.7.2 Bontac Beta-Nicotinamide Mononucleotide (NMN) Product Portfolio

7.7.3 Bontac Beta-Nicotinamide Mononucleotide (NMN) Production, Value, Price, and Gross Margin (2021–2026)

7.7.4 Bontac Main Business and Markets Served

7.7.5 Bontac Recent Developments/Updates

7.8 CELFULL

7.8.1 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Company Information

7.8.2 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Product Portfolio

7.8.3 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Production, Value, Price, and Gross Margin (2021–2026)

7.8.4 CELFULL Main Business and Markets Served

7.8.5 CELFULL Recent Developments/Updates

7.9 Kingdomway

7.9.1 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Company Information

7.9.2 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Product Portfolio

7.9.3 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Production, Value, Price, and Gross Margin (2021–2026)

7.9.4 Kingdomway Main Business and Markets Served

7.9.5 Kingdomway Recent Developments/Updates

7.10 ABA Chemical

7.10.1 ABA Chemical Beta-Nicotinamide Mononucleotide (NMN) Company Information

7.10.2 ABA Chemical Beta-Nicotinamide Mononucleotide (NMN) Product Portfolio

7.10.3 ABA Chemical Beta-Nicotinamide Mononucleotide (NMN) Production, Value, Price, and Gross Margin (2021–2026)

7.10.4 ABA Chemical Main Business and Markets Served

7.10.5 ABA Chemical Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

8.1 Beta-Nicotinamide Mononucleotide (NMN) Industry Chain Analysis

8.2 Beta-Nicotinamide Mononucleotide (NMN) Raw Material Supply Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 Beta-Nicotinamide Mononucleotide (NMN) Production Modes and Processes

8.4 Beta-Nicotinamide Mononucleotide (NMN) Sales and Marketing

8.4.1 Beta-Nicotinamide Mononucleotide (NMN) Sales Channels

8.4.2 Beta-Nicotinamide Mononucleotide (NMN) Distributors

8.5 Beta-Nicotinamide Mononucleotide (NMN) Customer Analysis

9 Beta-Nicotinamide Mononucleotide (NMN) Market Dynamics

9.1 Beta-Nicotinamide Mononucleotide (NMN) Industry Trends

9.2 Beta-Nicotinamide Mononucleotide (NMN) Market Drivers

9.3 Beta-Nicotinamide Mononucleotide (NMN) Market Challenges

9.4 Beta-Nicotinamide Mononucleotide (NMN) Market Restraints

9.5 Impact of U.S. Tariffs

10 Research Findings and Conclusion

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Beta-Nicotinamide Mononucleotide (NMN) Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Beta-Nicotinamide Mononucleotide (NMN) Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global Beta-Nicotinamide Mononucleotide (NMN) Production Capacity (Tons) by Manufacturers in 2025

Table 4. Global Beta-Nicotinamide Mononucleotide (NMN) Production by Manufacturers (Tons), 2021–2026

Table 5. Global Beta-Nicotinamide Mononucleotide (NMN) Production Market Share by Manufacturers (2021–2026)

Table 6. Global Beta-Nicotinamide Mononucleotide (NMN) Production Value by Manufacturers (US$ Million), 2021–2026

Table 7. Global Beta-Nicotinamide Mononucleotide (NMN) Production Value Share by Manufacturers (2021–2026)

Table 8. Global Key Players of Beta-Nicotinamide Mononucleotide (NMN), Industry Ranking, 2024 vs 2025

Table 9. Classification of Companies by Tier (Tier 1, Tier 2, Tier 3), based on Beta-Nicotinamide Mononucleotide (NMN) Production Value, 2025

Table 10. Global Market Beta-Nicotinamide Mononucleotide (NMN) Average Price by Manufacturers (US$/Kg), 2021–2026

Table 11. Global Key Manufacturers of Beta-Nicotinamide Mononucleotide (NMN), Manufacturing Footprints and Headquarters

Table 12. Global Key Manufacturers of Beta-Nicotinamide Mononucleotide (NMN), Product Offerings and Applications

Table 13. Global Key Manufacturers of Beta-Nicotinamide Mononucleotide (NMN), Date of Entry into the Industry

Table 14. Global Beta-Nicotinamide Mononucleotide (NMN) Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Mergers & Acquisitions and Expansion Plans

Table 16. Global Beta-Nicotinamide Mononucleotide (NMN) Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 17. Global Beta-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) by Region (2021–2026)

Table 18. Global Beta-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Region (2021–2026)

Table 19. Global Beta-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) Forecast by Region (2027–2032)

Table 20. Global Beta-Nicotinamide Mononucleotide (NMN) Production Value Market Share Forecast by Region (2027–2032)

Table 21. Global Beta-Nicotinamide Mononucleotide (NMN) Production Comparison by Region: 2021 vs 2025 vs 2032 (Tons)

Table 22. Global Beta-Nicotinamide Mononucleotide (NMN) Production (Tons) by Region (2021–2026)

Table 23. Global Beta-Nicotinamide Mononucleotide (NMN) Production Market Share by Region (2021–2026)

Table 24. Global Beta-Nicotinamide Mononucleotide (NMN) Production (Tons) Forecast by Region (2027–2032)

Table 25. Global Beta-Nicotinamide Mononucleotide (NMN) Production Market Share Forecast by Region (2027–2032)

Table 26. Global Beta-Nicotinamide Mononucleotide (NMN) Market Average Price (US$/Kg) by Region (2021–2026)

Table 27. Global Beta-Nicotinamide Mononucleotide (NMN) Market Average Price (US$/Kg) by Region (2027–2032)

Table 28. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (Tons)

Table 29. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption by Region (Tons), 2021–2026

Table 30. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Market Share by Region (2021–2026)

Table 31. Global Beta-Nicotinamide Mononucleotide (NMN) Forecasted Consumption by Region (Tons), 2027–2032

Table 32. Global Beta-Nicotinamide Mononucleotide (NMN) Forecasted Consumption Market Share by Region (2027–2032)

Table 33. North America Beta-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Tons)

Table 34. North America Beta-Nicotinamide Mononucleotide (NMN) Consumption by Country (Tons), 2021–2026

Table 35. North America Beta-Nicotinamide Mononucleotide (NMN) Consumption by Country (Tons), 2027–2032

Table 36. Europe Beta-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Tons)

Table 37. Europe Beta-Nicotinamide Mononucleotide (NMN) Consumption by Country (Tons), 2021–2026

Table 38. Europe Beta-Nicotinamide Mononucleotide (NMN) Consumption by Country (Tons), 2027–2032

Table 39. Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (Tons)

Table 40. Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Consumption by Region (Tons), 2021–2026

Table 41. Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Consumption by Region (Tons), 2027–2032

Table 42. Latin America, Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Tons)

Table 43. Latin America, Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Consumption by Country (Tons), 2021–2026

Table 44. Latin America, Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Consumption by Country (Tons), 2027–2032

Table 45. Global Beta-Nicotinamide Mononucleotide (NMN) Production (Tons) by Type (2021–2026)

Table 46. Global Beta-Nicotinamide Mononucleotide (NMN) Production (Tons) by Type (2027–2032)

Table 47. Global Beta-Nicotinamide Mononucleotide (NMN) Production Market Share by Type (2021–2026)

Table 48. Global Beta-Nicotinamide Mononucleotide (NMN) Production Market Share by Type (2027–2032)

Table 49. Global Beta-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) by Type (2021–2026)

Table 50. Global Beta-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) by Type (2027–2032)

Table 51. Global Beta-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Type (2021–2026)

Table 52. Global Beta-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Type (2027–2032)

Table 53. Global Beta-Nicotinamide Mononucleotide (NMN) Price (US$/Kg) by Type (2021–2026)

Table 54. Global Beta-Nicotinamide Mononucleotide (NMN) Price (US$/Kg) by Type (2027–2032)

Table 55. Global Beta-Nicotinamide Mononucleotide (NMN) Production (Tons) by Application (2021–2026)

Table 56. Global Beta-Nicotinamide Mononucleotide (NMN) Production (Tons) by Application (2027–2032)

Table 57. Global Beta-Nicotinamide Mononucleotide (NMN) Production Market Share by Application (2021–2026)

Table 58. Global Beta-Nicotinamide Mononucleotide (NMN) Production Market Share by Application (2027–2032)

Table 59. Global Beta-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) by Application (2021–2026)

Table 60. Global Beta-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) by Application (2027–2032)

Table 61. Global Beta-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Application (2021–2026)

Table 62. Global Beta-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Application (2027–2032)

Table 63. Global Beta-Nicotinamide Mononucleotide (NMN) Price (US$/Kg) by Application (2021–2026)

Table 64. Global Beta-Nicotinamide Mononucleotide (NMN) Price (US$/Kg) by Application (2027–2032)

Table 65. GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Company Information

Table 66. GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Specification and Application

Table 67. GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 68. GeneHarbor Main Business and Markets Served

Table 69. GeneHarbor Recent Developments/Updates

Table 70. Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Company Information

Table 71. Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Specification and Application

Table 72. Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 73. Herbalmax Main Business and Markets Served

Table 74. Herbalmax Recent Developments/Updates

Table 75. Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Company Information

Table 76. Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Specification and Application

Table 77. Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 78. Genex Formulas Main Business and Markets Served

Table 79. Genex Formulas Recent Developments/Updates

Table 80. Mirailab Bioscience Beta-Nicotinamide Mononucleotide (NMN) Company Information

Table 81. Mirailab Bioscience Beta-Nicotinamide Mononucleotide (NMN) Specification and Application

Table 82. Mirailab Bioscience Beta-Nicotinamide Mononucleotide (NMN) Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 83. Mirailab Bioscience Main Business and Markets Served

Table 84. Mirailab Bioscience Recent Developments/Updates

Table 85. Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Company Information

Table 86. Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Specification and Application

Table 87. Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 88. Maac10 Formulas Main Business and Markets Served

Table 89. Maac10 Formulas Recent Developments/Updates

Table 90. EffePharm Beta-Nicotinamide Mononucleotide (NMN) Company Information

Table 91. EffePharm Beta-Nicotinamide Mononucleotide (NMN) Specification and Application

Table 92. EffePharm Beta-Nicotinamide Mononucleotide (NMN) Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 93. EffePharm Main Business and Markets Served

Table 94. EffePharm Recent Developments/Updates

Table 95. Bontac Beta-Nicotinamide Mononucleotide (NMN) Company Information

Table 96. Bontac Beta-Nicotinamide Mononucleotide (NMN) Specification and Application

Table 97. Bontac Beta-Nicotinamide Mononucleotide (NMN) Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 98. Bontac Main Business and Markets Served

Table 99. Bontac Recent Developments/Updates

Table 100. CELFULL Beta-Nicotinamide Mononucleotide (NMN) Company Information

Table 101. CELFULL Beta-Nicotinamide Mononucleotide (NMN) Specification and Application

Table 102. CELFULL Beta-Nicotinamide Mononucleotide (NMN) Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 103. CELFULL Main Business and Markets Served

Table 104. CELFULL Recent Developments/Updates

Table 105. Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Company Information

Table 106. Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Specification and Application

Table 107. Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 108. Kingdomway Main Business and Markets Served

Table 109. Kingdomway Recent Developments/Updates

Table 110. ABA Chemical Beta-Nicotinamide Mononucleotide (NMN) Company Information

Table 111. ABA Chemical Beta-Nicotinamide Mononucleotide (NMN) Specification and Application

Table 112. ABA Chemical Beta-Nicotinamide Mononucleotide (NMN) Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 113. ABA Chemical Main Business and Markets Served

Table 114. ABA Chemical Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Beta-Nicotinamide Mononucleotide (NMN) Distributors List

Table 118. Beta-Nicotinamide Mononucleotide (NMN) Customers List

Table 119. Beta-Nicotinamide Mononucleotide (NMN) Market Trends

Table 120. Beta-Nicotinamide Mononucleotide (NMN) Market Drivers

Table 121. Beta-Nicotinamide Mononucleotide (NMN) Market Challenges

Table 122. Beta-Nicotinamide Mononucleotide (NMN) Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of Beta-Nicotinamide Mononucleotide (NMN)

Figure 2. Global Beta-Nicotinamide Mononucleotide (NMN) Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Beta-Nicotinamide Mononucleotide (NMN) Market Share by Type: 2025 vs 2032

Figure 4. Content ≥98% Product Picture

Figure 5. Content ＜98% Product Picture

Figure 6. Global Beta-Nicotinamide Mononucleotide (NMN) Market Value by Application (US$ Million), 2021–2032

Figure 7. Global Beta-Nicotinamide Mononucleotide (NMN) Market Share by Application: 2025 vs 2032

Figure 8. Health Care Products

Figure 9. Cosmetics

Figure 10. Others

Figure 11. Global Beta-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million), 2021 vs 2025 vs 2032

Figure 12. Global Beta-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million), 2021–2032

Figure 13. Global Beta-Nicotinamide Mononucleotide (NMN) Production Capacity (Tons), 2021–2032

Figure 14. Global Beta-Nicotinamide Mononucleotide (NMN) Production (Tons), 2021–2032

Figure 15. Global Beta-Nicotinamide Mononucleotide (NMN) Average Price (US$/Kg), 2021–2032

Figure 16. Beta-Nicotinamide Mononucleotide (NMN) Report Years Considered

Figure 17. Beta-Nicotinamide Mononucleotide (NMN) Production Share by Manufacturers in 2025

Figure 18. Global Beta-Nicotinamide Mononucleotide (NMN) Production Value Share by Manufacturers (2025)

Figure 19. Beta-Nicotinamide Mononucleotide (NMN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 20. Top 5 and Top 10 Global Players: Market Share by Beta-Nicotinamide Mononucleotide (NMN) Revenue in 2025

Figure 21. Global Beta-Nicotinamide Mononucleotide (NMN) Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)

Figure 22. Global Beta-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Region: 2021 vs 2025 vs 2032

Figure 23. Global Beta-Nicotinamide Mononucleotide (NMN) Production Comparison by Region: 2021 vs 2025 vs 2032 (Tons)

Figure 24. Global Beta-Nicotinamide Mononucleotide (NMN) Production Market Share by Region: 2021 vs 2025 vs 2032

Figure 25. North America Beta-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) Growth Rate (2021–2032)

Figure 26. China Beta-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) Growth Rate (2021–2032)

Figure 27. Japan Beta-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) Growth Rate (2021–2032)

Figure 28. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption by Region: 2021 vs 2025 vs 2032 (Tons)

Figure 29. Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Market Share by Region: 2021 vs 2025 vs 2032

Figure 30. North America Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032

Figure 31. North America Beta-Nicotinamide Mononucleotide (NMN) Consumption Market Share by Country (2021–2032)

Figure 32. U.S. Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032

Figure 33. Canada Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032

Figure 34. Europe Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032

Figure 35. Europe Beta-Nicotinamide Mononucleotide (NMN) Consumption Market Share by Country (2021–2032)

Figure 36. Germany Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032

Figure 37. France Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032

Figure 38. U.K. Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032

Figure 39. Italy Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032

Figure 40. Russia Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032

Figure 41. Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032

Figure 42. Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Consumption Market Share by Region (2021–2032)

Figure 43. China Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032

Figure 44. Japan Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032

Figure 45. South Korea Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032

Figure 46. China Taiwan Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032

Figure 47. Southeast Asia Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032

Figure 48. India Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032

Figure 49. Latin America, Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032

Figure 50. Latin America, Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Consumption Market Share by Country (2021–2032)

Figure 51. Mexico Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032

Figure 52. Brazil Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032

Figure 53. Turkey Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032

Figure 54. GCC Countries Beta-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (Tons), 2021–2032

Figure 55. Global Production Market Share of Beta-Nicotinamide Mononucleotide (NMN) by Type (2021–2032)

Figure 56. Global Production Value Market Share of Beta-Nicotinamide Mononucleotide (NMN) by Type (2021–2032)

Figure 57. Global Beta-Nicotinamide Mononucleotide (NMN) Price (US$/Kg) by Type (2021–2032)

Figure 58. Global Production Market Share of Beta-Nicotinamide Mononucleotide (NMN) by Application (2021–2032)

Figure 59. Global Production Value Market Share of Beta-Nicotinamide Mononucleotide (NMN) by Application (2021–2032)

Figure 60. Global Beta-Nicotinamide Mononucleotide (NMN) Price (US$/Kg) by Application (2021–2032)

Figure 61. Beta-Nicotinamide Mononucleotide (NMN) Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

KEY QUESTIONS ADDRESSED BY THE REPORT

What is the annual compound growth rate of the global Beta-Nicotinamide Mononucleotide (NMN) market size from 2026 to 2032? zhanKai

The annual compound growth rate of the global Beta-Nicotinamide Mononucleotide (NMN) market is 13.4% 2026 to 2032.

Which region is expected to have the highest market share? shouQi

Which companies rank high in the global Beta-Nicotinamide Mononucleotide (NMN) market? shouQi

What was the global market size of Beta-Nicotinamide Mononucleotide (NMN) in 2026? shouQi

What was the global market size of Beta-Nicotinamide Mononucleotide (NMN) in 2032? shouQi

Related Reports

Beta-Nicotinamide Mononucleotide (NMN)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Beta-Nicotinamide Mononucleotide (NMN) was estimated to be worth US$ 468 million in 2025 and is projected to reach US$ 1112 million, growing at a CAGR of 13.4% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 99
USD 3950.00
(Single User License)
Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Beta-Nicotinamide Mononucleotide (NMN) market size was US$ 468 million in 2025 and is forecast to reach a readjusted size of US$ 1112 million by 2032 with a CAGR of 13.4% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 80
USD 4250.00
(Single User License)
Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Beta-Nicotinamide Mononucleotide (NMN) market size was US$ 418 million in 2024 and is forecast to a readjusted size of US$ 992 million by 2031 with a CAGR of 13.4% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 79
USD 4250.00
(Single User License)
Global Beta-Nicotinamide Mononucleotide (NMN) Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Beta-Nicotinamide Mononucleotide (NMN) market is projected to grow from US$ 418 million in 2024 to US$ 992 million by 2031, at a CAGR of 13.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 132
USD 4900.00
(Single User License)
Global Beta-Nicotinamide Mononucleotide (NMN) Market Research Report 2025
The global market for Beta-Nicotinamide Mononucleotide (NMN) was valued at US$ 418 million in the year 2024 and is projected to reach a revised size of US$ 992 million by 2031, growing at a CAGR of 13.4% during the forecast period.
Published Date: 2025-02-09
Pages: 91
USD 2900.00
(Single User License)
Beta-Nicotinamide Mononucleotide (NMN)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Beta-Nicotinamide Mononucleotide (NMN) was estimated to be worth US$ 418 million in 2024 and is forecast to a readjusted size of US$ 992 million by 2031 with a CAGR of 13.4% during the forecast period 2025-2031.
Published Date: 2025-02-07
Pages: 97
USD 3950.00
(Single User License)
Global and Japan Beta-Nicotinamide Mononucleotide (NMN) Market Report & Forecast 2024-2030
The global Beta-Nicotinamide Mononucleotide (NMN) revenue was US$ 373 million in 2023 and is forecast to a readjusted size of US$ 886 million by 2030 with a CAGR of 13.4% during the review period (2024-2030).
Published Date: 2024-12-20
Pages: 120
USD 4350.00
(Single User License)
Beta-Nicotinamide Mononucleotide (NMN)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Beta-Nicotinamide Mononucleotide (NMN) was estimated to be worth US$ 373 million in 2023 and is forecast to a readjusted size of US$ 886 million by 2030 with a CAGR of 13.4% during the forecast period 2024-2030.
Published Date: 2024-12-20
Pages: 108
USD 3950.00
(Single User License)
Global Beta-Nicotinamide Mononucleotide (NMN) Market Insights, Forecast to 2030
Valued at US$ 418 million in 2024, the global Beta-Nicotinamide Mononucleotide (NMN) market is forecast to reach US$ 886 million by 2030, at a CAGR of 13.4% during the forecast period.
Published Date: 2024-12-20
Pages: 140
USD 4900.00
(Single User License)
Global Beta-Nicotinamide Mononucleotide (NMN) Market Research Report 2024
The global market for Beta-Nicotinamide Mononucleotide (NMN) was valued at US$ 373 million in the year 2023 and is projected to reach a revised size of US$ 886 million by 2030, growing at a CAGR of 13.4% during the forecast period.
Published Date: 2024-12-20
Pages: 93
USD 2900.00
(Single User License)

Beta-Nicotinamide Mononucleotide (NMN)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Beta-Nicotinamide Mononucleotide (NMN) was estimated to be worth US$ 468 million in 2025 and is projected to reach US$ 1112 million, growing at a CAGR of 13.4% from 2026 to 2032.
Published: 2026-01-09
Pages: 99
USD 3950.00 (Single User License)
Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Beta-Nicotinamide Mononucleotide (NMN) market size was US$ 468 million in 2025 and is forecast to reach a readjusted size of US$ 1112 million by 2032 with a CAGR of 13.4% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 80
USD 4250.00 (Single User License)
Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Beta-Nicotinamide Mononucleotide (NMN) market size was US$ 418 million in 2024 and is forecast to a readjusted size of US$ 992 million by 2031 with a CAGR of 13.4% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 79
USD 4250.00 (Single User License)
Global Beta-Nicotinamide Mononucleotide (NMN) Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Beta-Nicotinamide Mononucleotide (NMN) market is projected to grow from US$ 418 million in 2024 to US$ 992 million by 2031, at a CAGR of 13.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 132
USD 4900.00 (Single User License)
Global Beta-Nicotinamide Mononucleotide (NMN) Market Research Report 2025
The global market for Beta-Nicotinamide Mononucleotide (NMN) was valued at US$ 418 million in the year 2024 and is projected to reach a revised size of US$ 992 million by 2031, growing at a CAGR of 13.4% during the forecast period.
Published: 2025-02-09
Pages: 91
USD 2900.00 (Single User License)
Beta-Nicotinamide Mononucleotide (NMN)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Beta-Nicotinamide Mononucleotide (NMN) was estimated to be worth US$ 418 million in 2024 and is forecast to a readjusted size of US$ 992 million by 2031 with a CAGR of 13.4% during the forecast period 2025-2031.
Published: 2025-02-07
Pages: 97
USD 3950.00 (Single User License)
Global and Japan Beta-Nicotinamide Mononucleotide (NMN) Market Report & Forecast 2024-2030
The global Beta-Nicotinamide Mononucleotide (NMN) revenue was US$ 373 million in 2023 and is forecast to a readjusted size of US$ 886 million by 2030 with a CAGR of 13.4% during the review period (2024-2030).
Published: 2024-12-20
Pages: 120
USD 4350.00 (Single User License)
Beta-Nicotinamide Mononucleotide (NMN)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Beta-Nicotinamide Mononucleotide (NMN) was estimated to be worth US$ 373 million in 2023 and is forecast to a readjusted size of US$ 886 million by 2030 with a CAGR of 13.4% during the forecast period 2024-2030.
Published: 2024-12-20
Pages: 108
USD 3950.00 (Single User License)
Global Beta-Nicotinamide Mononucleotide (NMN) Market Insights, Forecast to 2030
Valued at US$ 418 million in 2024, the global Beta-Nicotinamide Mononucleotide (NMN) market is forecast to reach US$ 886 million by 2030, at a CAGR of 13.4% during the forecast period.
Published: 2024-12-20
Pages: 140
USD 4900.00 (Single User License)
Global Beta-Nicotinamide Mononucleotide (NMN) Market Research Report 2024
The global market for Beta-Nicotinamide Mononucleotide (NMN) was valued at US$ 373 million in the year 2023 and is projected to reach a revised size of US$ 886 million by 2030, growing at a CAGR of 13.4% during the forecast period.
Published: 2024-12-20
Pages: 93
USD 2900.00 (Single User License)